The eugenicist of UNESCO
By Stefan Bernhardt-Radu,
Aeon
| 12. 02. 2024
Why did Julian S Huxley, first director of the UN agency, think eugenics held the key to a more evolved, harmonious world?
In the 18th century, European scholars began to envision a more enlightened world in harmony with nature. The old aristocratic regime, some hoped, would soon be replaced by a progressive society in which moral and social values were aligned with the natural and mechanical sciences. Aligning with nature, however, was not always a straightforward or positive process. In an enlightened world, human populations could not expand indefinitely. Resources would quickly become depleted by growing demand, which would slow progress and send humanity backward. That is why, at the end of the century, the British economist Thomas Malthus proposed that the growth of human populations needed to be kept in check. Like other species that were held in equilibrium with their environment, we should also find a balance between the supply of available resources and their demand. But if we failed to control our own populations, Malthus believed that war, famine or disease would do it for us. For humanity to advance, we needed hard limits.
Malthus’s ideas emerged at a time when Britain was being socially reconfigured. Rapid industrialisation and...
Related Articles
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...
By Ben Fidler and Ned Pagliarulo, Biopharma Dive | 07.21.2025
One month ago, a 51-year-old man treated in a clinical trial with an experimental gene therapy became dangerously sick. The developer of that treatment, Sarepta Therapeutics, informed the Food and Drug Administration his case could be life-threatening.
The man died...
By Pat Duggins, Alabama Public Radio | 06.27.2025
PAT DUGGINS-- If I were to say, ‘man, have you seen the price of eggs these days?’ You're probably thinking, Oh, he's talking about inflation and the price of groceries and how it became an issue in the presidential race...